Orisild (Sildenafil)

Sildenafil, the active ingredient in Orisild, is a phosphodiesterase type 5 (PDE‑5) inhibitor presented as a tablet for oral use. It is indicated for the treatment of erectile dysfunction in adult males. GNH USA supplies Orisild as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Orisild as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Sildenafil acts on the nitric‑oxide/cGMP pathway to improve blood flow in specific vascular beds.

- Erectile dysfunction: improves the ability to achieve and maintain an erection suitable for sexual activity. - Pulmonary arterial hypertension: lowers pulmonary arterial pressure and improves exercise capacity. - Secondary use of off‑label research only : investigates potential benefits in certain cardiovascular conditions "